ArticleJournal of virology1996
High-dose ocular infection with a herpes simplex virus type 1 ICP34.5 deletion mutant produces no corneal disease or neurovirulence yet results in wild-type levels of spontaneous reactivation.
Article in Journal of virology, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 43 citations in OpenAlex.
- Towards a comprehensive view of the herpes B virus.Frontiers in immunology · 2023Review
- Blocking Autophagy in M1 Macrophages Enhances Virus Replication and Eye Disease in Ocularly Infected Transgenic Mice.Journal of virology · 2022Article
- "Non-Essential" Proteins of HSV-1 with Essential Roles In Vivo: A Comprehensive Review.Viruses · 2020Review
- Herpes Simplex Virus 1 γJournal of virology · 2018Article
- Role of Herpes Simplex Virus 1 γ34.5 in the Regulation of IRF3 Signaling.Journal of virology · 2017Article
- A herpes simplex virus type 1 mutant disrupted for microRNA H2 with increased neurovirulence and rate of reactivation.Journal of neurovirology · 2015Article
- Roles of conserved residues within the pre-NH2-terminal domain of herpes simplex virus 1 DNA polymerase in replication and latency in mice.The Journal of general virology · 2014Article
- Ocular and neural distribution of feline herpesvirus-1 during active and latent experimental infection in cats.BMC veterinary research · 2013Article
- Inhibition of TANK binding kinase 1 by herpes simplex virus 1 facilitates productive infection.Journal of virology · 2012Article
- Cellular FLIP can substitute for the herpes simplex virus type 1 latency-associated transcript gene to support a wild-type virus reactivation phenotype in mice.Journal of neurovirology · 2008Article
- The high prevalence of herpes simplex virus type 1 DNA in human trigeminal ganglia is not a function of age or gender.Journal of virology · 2008Article
- Analysis of the role of autophagy in replication of herpes simplex virus in cell culture.Journal of virology · 2007Article
- A mutant deleted for most of the herpes simplex virus type 1 (HSV-1) UOL gene does not affect the spontaneous reactivation phenotype in rabbits.Journal of neurovirology · 2006Article
- A herpes simplex virus type 1 mutant expressing a baculovirus inhibitor of apoptosis gene in place of latency-associated transcript has a wild-type reactivation phenotype in the mouse.Journal of virology · 2005Article
- Peculiarities of herpes simplex virus (HSV) transcription: an overview.Virus genes · 2004Review
- Failure of thymidine kinase-negative herpes simplex virus to reactivate from latency following efficient establishment.Journal of virology · 2004Article
- A gene capable of blocking apoptosis can substitute for the herpes simplex virus type 1 latency-associated transcript gene and restore wild-type reactivation levels.Journal of virology · 2002Article
- A herpes simplex virus type 1 mutant deleted for gamma34.5 and LAT kills glioma cells in vitro and is inhibited for in vivo reactivation.Cancer gene therapy · 2001Article
- Herpes simplex virus 1 open reading frames O and P are not necessary for establishment of latent infection in mice.Journal of virology · 2000Article
- Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants To establish wild-type levels of latency in vivo.Journal of virology · 2000Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
Abstract
We report here that in the rabbit ocular model of herpes simplex virus type 1 (HSV-1) latency, spontaneous reactivation of the HSV-1 ICP34.5 deletion mutant d34.5 increased significantly in response to increasing infectious doses. At the highest infectious dose of d34.5, the spontaneous reactivation rate was indistinguishable from that of wild-type virus (average spontaneous reactivation rates for d34.5, 0.3 to 1.4% at 2 x 10(5) PFU per eye, 3.4% at 2 x 10(6) PFU per eye, and 6.3 to 11.5% at 1 x 10(8) PFU per eye; average spontaneous reactivation rates for marker-rescued virus, 7.7 to 19.6% at 2 x 10(5) PFU per eye). The percentage of latency-associated transcript (LAT) RNA-positive neurons in sections from trigeminal ganglia (TG) of rabbits latently infected with d34.5 demonstrated a similar dose-response effect as estimated by in situ hybridization (0.05% LAT RNA-positive neurons at 2 x 10(5) PFU per eye and 0.1% LAT RNA-positive neurons at 1 x 10(8) PFU per eye; P = 0.002). In contrast, even at the highest infectious dose (1 x 10(8) PFU per eye), d34.5 was less virulent (23 of 23 survivors) than the normal infectious dose (2 x 10(5) PFU per eye) of marker-rescued virus (14 of 27 survivors; P < 0.0001). In addition, at 1 x 10(8) PFU per eye, d34.5 produced virtually no corneal disease, compared with the production of severe corneal disease by 2 x 10(5) PFU of marker-rescued virus per eye (P < 0.0001). Thus, at increasing infectious doses of d34.5, both spontaneous reactivation and the percentage of neurons expressing LAT appeared to increase, without a corresponding increase in virulence. These results strongly suggest that (i) the phenotypes of neurovirulence and spontaneous reactivation are separable, (ii) the phenotypes of corneal disease and spontaneous reactivation are separable, and (iii) the decreased rate of spontaneous reactivation previously reported for d34.5 (G. C. Perng, R. L. Thompson, N. M. Sawtell, W. E. Taylor, S. M. Slanina, H. Ghiasi, R. Kaiwar, A. B. Nesburn, and S. L. Wechsler, J. Virol. 69:3033-3041, 1995) is at least partially due to a reduced rate of establishing latency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.